Fig. 2. Differences in cellular resistance between DS AML and non-DS AML for (A) cytarabine (Ara-C) and daunorubicin (DNR), (B) etoposide and 6-thioguanine (6-TG), (C) vincristine (VCR) and prednisolone (Pred), (D) L-asparaginase (L-ASP) and ifosfamide (Ifos). / DS AML is significantly more sensitive to cytarabine (median, 11.5-fold), daunorubicin (2.2-fold), etoposide (20.1-fold), 6-thioguanine (2.7-fold), vincristine (23.0-fold), and prednisolone (more than 1.1-fold). However, the differences for L-asparaginase and 4-hydroperoxy ifosfamide were not significant. The median LC50 value is depicted as a horizontal solid line, and the 25th and 75th percentiles are depicted as triangles. More results are shown in Table 2.
Fig. 2.

Differences in cellular resistance between DS AML and non-DS AML for (A) cytarabine (Ara-C) and daunorubicin (DNR), (B) etoposide and 6-thioguanine (6-TG), (C) vincristine (VCR) and prednisolone (Pred), (D) L-asparaginase (L-ASP) and ifosfamide (Ifos).

DS AML is significantly more sensitive to cytarabine (median, 11.5-fold), daunorubicin (2.2-fold), etoposide (20.1-fold), 6-thioguanine (2.7-fold), vincristine (23.0-fold), and prednisolone (more than 1.1-fold). However, the differences for L-asparaginase and 4-hydroperoxy ifosfamide were not significant. The median LC50 value is depicted as a horizontal solid line, and the 25th and 75th percentiles are depicted as triangles. More results are shown in Table 2.

or Create an Account

Close Modal
Close Modal